603087 甘李药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)7.3275.6403.346-4.45015.207
总资产报酬率 ROA (%)6.7675.1743.047-4.09614.270
投入资产回报率 ROIC (%)7.2785.5973.318-4.40615.039

边际利润分析
销售毛利率 (%)76.18274.83073.25976.30089.034
营业利润率 (%)28.50820.73812.089-33.22347.035
息税前利润/营业总收入 (%)28.36117.4738.720-39.52542.057
净利润/营业总收入 (%)26.85720.18413.046-25.66940.220

收益指标分析
经营活动净收益/利润总额(%)83.29860.61198.43788.69193.766
价值变动净收益/利润总额(%)8.95434.56014.835-1.1875.049
营业外收支净额/利润总额(%)6.164-0.183-2.9872.335-0.171

偿债能力分析
流动比率 (X)7.1964.7327.9856.96714.150
速动比率 (X)5.5663.4186.8726.16912.809
资产负债率 (%)7.0858.2088.3019.6286.321
带息债务/全部投入资本 (%)-0.968-0.858-1.134-1.156-0.949
股东权益/带息债务 (%)-10,277.648-11,561.713-8,756.858-8,562.875-10,432.315
股东权益/负债合计 (%)1,311.3491,118.3691,104.609938.6131,482.069
利息保障倍数 (X)-14.044-5.414-2.8897.177-8.588

营运能力分析
应收账款周转天数 (天)32.93435.31338.649116.69487.751
存货周转天数 (天)405.140449.330389.502576.622520.223